391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 391 G is Purple, Elliptical / Oval and has been identified as Carbidopa and levodopa extended release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 391 G

Save up to 80% off prescription medications

Click here for your free Discount Card

Carbidopa and levodopa extended release

Imprint:

391 G

Strength:

50 mg / 200 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Global Pharmaceuticals

Inactive Ingredients:

hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.